Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RaySearch Laboratories ABOSTO:RAY B +2.01%91 FCF Yield % is 1.91 as of Jul. 21, 2026, which is 64% below its 10-year median of 5.27. GuruFocus rates OSTO:RAY B with a GF Score™ of 91/100 and a GF Value™ of kr193.00 (Fairly Valued). The stock has 2 warning signs investors should review. Among 684 Healthcare Providers & Services companies, RaySearch Laboratories AB ranks better than 50.29% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for RaySearch Laboratories AB's FCF Yield % or its related term are showing as below:
OSTO:RAY B'
s FCF Yield % Range Over the Past 10 Years
Min: 0.94 Med: 5.27 Max: 17.4
Current: 1.91
During the past 13 years, the highest FCF Yield % of RaySearch Laboratories AB was 17.40%. The lowest was 0.94%. And the median was 5.27%.
OSTO:RAY B's FCF Yield % is ranked better than 50.29% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 1.88
vs OSTO:RAY B: 1.91
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
RaySearch Laboratories AB FCF Yield % Related Terms
RaySearch Laboratories AB FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:RAY B vs VEEV, BTSG, TEM: FCF Yield % Comparison
For the Health Information Services subindustry, RaySearch Laboratories AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RaySearch Laboratories AB FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where RaySearch Laboratories AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RaySearch Laboratories AB (OSTO:RAY B) has a FCF Yield % of 1.91 as of Jul. 21, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on RaySearch Laboratories AB and its competitors. This is 64% below median its historical median of 5.27. Over the past decade, RaySearch Laboratories AB's FCF Yield % has ranged from 0.94 to 17.40. According to the industry distribution chart, RaySearch Laboratories AB ranks #340 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 49.7%.
Is RaySearch Laboratories AB's FCF Yield % too high?
RaySearch Laboratories AB's current FCF Yield % of 1.91 is 64% below median its 10-year median of 5.27. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 17.40. The Healthcare Providers & Services industry median FCF Yield % is 1.88. RaySearch Laboratories AB's value of 1.91 is 1.6% above this industry median. Based on the distribution chart, RaySearch Laboratories AB ranks #340 out of 684 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, RaySearch Laboratories AB has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's FCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, RaySearch Laboratories AB ranks #340 out of 684 companies for FCF Yield %. This puts RaySearch Laboratories AB in the upper half of its industry. The industry median FCF Yield % is 1.88. RaySearch Laboratories AB's value of 1.91 is 1.6% above this benchmark. Historically, RaySearch Laboratories AB's own FCF Yield % has ranged from 0.94 to 17.40 over the past decade. While the company's 10-year median is 5.27 vs. the industry median of 1.88, RaySearch Laboratories AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.88, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RaySearch Laboratories AB's current FCF Yield % of 1.91 is 1.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on RaySearch Laboratories AB and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RaySearch Laboratories AB's current FCF Yield % is 1.91, which is 64% below median its own 10-year median of 5.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (OSTO:RAY B) is currently considered Fairly Valued. The stock's GF Value™ is kr193.00, compared to a current price of kr177.90 — trading 7.8% below its estimated fair value. The current FCF Yield % is 1.91, which is 64% below median its 10-year median of 5.27 and 1.6% above the Healthcare Providers & Services industry median of 1.88. RaySearch Laboratories AB's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For RaySearch Laboratories AB (OSTO:RAY B), the current FCF Yield % is 1.91 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RaySearch Laboratories AB (OSTO:RAY B) Overvalued in 2026?
Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be undervalued.
The current stock price of kr177.90 is trading 7.8% below its estimated GF Value™ of kr193.00.
GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.
Key valuation signals for OSTO:RAY B:
FCF Yield %: 1.91 (64% below median its 10-year median of 5.27)
GF Value™: kr193.00 vs. price of kr177.90 (7.8% below fair value)
Industry Position: 1.6% above the Healthcare Providers & Services median (#340 of 684)
No single metric tells the full story. See the OSTO:RAY B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
91GF Score
Get the complete analysis for OSTO:RAY B
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:RAY B has been successfully added to your 
